Enabling Nucleic  Acid-Based Medicines to Treat Solid Tumor Cancers          Ground-breaking  Impilo Platform™ The Impilo Platform™ is designed to address key issues that have limited ability of emerging nucleic acid-based therapeutic modalities such as antisense, siRNA, tRNA, and mRNA and in vivo gene editing to effectively treat solid tumor cancers.